Clinical Trials Browser

Phase 2 × Neoplasms, Germ Cell and Embryonal × Erlotinib Hydrochloride × Clear all

NCT01962896 2019-02-26

A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors

Phase 2 Terminated

4 enrolled 6 charts

Neoplasms, Germ Cell and Embryonal